Blog

EHS Information

Notice on the 2025 Edition of the Chinese Pharmacopoeia Standard Interpretation Training Class (Guangzhou Second Session)

Notice on the 2025 Edition of the Chinese Pharmacopoeia Standard Interpretation Training Class (Guangzhou Second Session)

06

2025

/

05

Announcement on the Release of the Reference Drug List for Generic Drugs (91st Batch) (No. 15 of 2025) by the National Medical Products Administration. This is hereby announced.

Announcement on the Release of the Reference Drug List for Generic Drugs (91st Batch) (No. 15 of 2025) by the National Medical Products Administration. This is hereby announced.

23

2025

/

04

National Medical Products Administration Center for Drug and Food Review and Inspection, Announcement on the Issuance of the "Key Points and Criteria for Supervision and Inspection of Drug Clinical Trial Institutions (Trial)" (No. 9 of 2023)

21

2025

/

04

National Medical Products Administration Announcement on Further Improving the Issuance of Pharmaceutical Production Licenses (No. 35 of 2025)

National Medical Products Administration Announcement on Further Improving the Issuance of Pharmaceutical Production Licenses (No. 35 of 2025)

21

2025

/

04

Notice on the 2025 Edition of the Chinese Pharmacopoeia Standard Interpretation Training Class (Guangzhou)

Notice on the 2025 Edition of the Chinese Pharmacopoeia Standard Interpretation Training Class (Guangzhou)

03

2025

/

04

Pharmaceutical Administration Law of the People's Republic of China

Pharmaceutical Administration Law of the People's Republic of China

02

2025

/

04

< 1 2 3 >

5

86020-8985 8964

8

E-mial

pvreport@bio-current.com

9

Tel

86020-8985 8964

Address: Room 803, Building B3, Science and Technology Enterprise Accelerator, No.11 Kaiyuan Avenue, Huangpu District, Guangzhou

Telephone:020-8985 8964

Production Base

Address: No.80, Spring Equinox Road, Huangpu District, Guangzhou

Telephone:020-8328 9091

Adverse Drug Reaction/Event Feedback E-mail:pvreport@bio-current.com

WeChat

Copyright©2024 All Rights Reserved of Guangzhou Keruite Pharmaceutical Co., Ltd.

Business License